Basic and clinical research in oncology: is there background for a breakthrough?

<p>The appearance of anticancer drugs dramatically changed cancer treatment, allowing patients with a number of previously fatal diseases to achieve cure and prolong life in patients with incurable tumors. More than 100 anticancer drugs registered to date, many of which have been<br />de...

Full description

Bibliographic Details
Main Authors:	N. V. Zhukov, S. A. Rumyantsev, S. A. Lukyanov
Format:	Article
Language:	Russian
Published:	ABV-press 2015-01-01
Series:	Onkogematologiâ
Subjects:	malignant tumors cancer therapy clinical trials treatment standards pharmacoeconomics
Online Access:	http://oncohematology.abvpress.ru/index.php/ongm/article/view/132

id	doaj-abf1ca2b01a3439ead492600f1c496e4
record_format	Article
spelling	doaj-abf1ca2b01a3439ead492600f1c496e42020-11-24T22:35:23ZrusABV-pressOnkogematologiâ1818-83462015-01-01945466147Basic and clinical research in oncology: is there background for a breakthrough?N. V. Zhukov0S. A. Rumyantsev1S. A. Lukyanov2N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow; 1, Ostrovityanova st., Moscow, Russia,117997 Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitriy Rogachev, Ministry of Health of Russia, Moscow; 1, Samory Mashela st., Moscow, Russia, 117198N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow; 1, Ostrovityanova st., Moscow, Russia,117997 Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitriy Rogachev, Ministry of Health of Russia, Moscow; 1, Samory Mashela st., Moscow, Russia, 117198N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow; 1, Ostrovityanova st., Moscow, Russia,117997 M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow; 16/10, Miklukho-Maklaya st., Moscow, GSP-7, Russia, 117997<p>The appearance of anticancer drugs dramatically changed cancer treatment, allowing patients with a number of previously fatal diseases to achieve cure and prolong life in patients with incurable tumors. More than 100 anticancer drugs registered to date, many of which have been<br />developed in recent years using the latest advances in tumors molecular biology. At the same time the price of new anticancer drugs increases<br />much faster than efficacy of anticancer therapy. The situation is due largely to the fact that the current system of introduction of new anticancer drugs not performing initial tasks.</p>http://oncohematology.abvpress.ru/index.php/ongm/article/view/132malignant tumorscancer therapyclinical trialstreatment standardspharmacoeconomics
collection	DOAJ
language	Russian
format	Article
sources	DOAJ
author	N. V. Zhukov S. A. Rumyantsev S. A. Lukyanov
spellingShingle	N. V. Zhukov S. A. Rumyantsev S. A. Lukyanov Basic and clinical research in oncology: is there background for a breakthrough? Onkogematologiâ malignant tumors cancer therapy clinical trials treatment standards pharmacoeconomics
author_facet	N. V. Zhukov S. A. Rumyantsev S. A. Lukyanov
author_sort	N. V. Zhukov
title	Basic and clinical research in oncology: is there background for a breakthrough?
title_short	Basic and clinical research in oncology: is there background for a breakthrough?
title_full	Basic and clinical research in oncology: is there background for a breakthrough?
title_fullStr	Basic and clinical research in oncology: is there background for a breakthrough?
title_full_unstemmed	Basic and clinical research in oncology: is there background for a breakthrough?
title_sort	basic and clinical research in oncology: is there background for a breakthrough?
publisher	ABV-press
series	Onkogematologiâ
issn	1818-8346
publishDate	2015-01-01
description	<p>The appearance of anticancer drugs dramatically changed cancer treatment, allowing patients with a number of previously fatal diseases to achieve cure and prolong life in patients with incurable tumors. More than 100 anticancer drugs registered to date, many of which have been<br />developed in recent years using the latest advances in tumors molecular biology. At the same time the price of new anticancer drugs increases<br />much faster than efficacy of anticancer therapy. The situation is due largely to the fact that the current system of introduction of new anticancer drugs not performing initial tasks.</p>
topic	malignant tumors cancer therapy clinical trials treatment standards pharmacoeconomics
url	http://oncohematology.abvpress.ru/index.php/ongm/article/view/132
work_keys_str_mv	AT nvzhukov basicandclinicalresearchinoncologyistherebackgroundforabreakthrough AT sarumyantsev basicandclinicalresearchinoncologyistherebackgroundforabreakthrough AT salukyanov basicandclinicalresearchinoncologyistherebackgroundforabreakthrough
_version_	1725723588255809536

Basic and clinical research in oncology: is there background for a breakthrough?

Similar Items